 New York, New York--Newsfile Corp. - March 29, 2021 - Pomerantz LLP announces that a class action lawsuit has been filed against Immunovant, Inc. fka Health Sciences Acquisitions Corporation HSAC, Immunovant, or the Company NASDAQ: IMVT; HSACU; HSAC; and HSACW and certain of its officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-00918, is on behalf of a class consisting... 